HEUKING advises Luxempart S.A. on the acquisition of a majority interest in VALEARA group from GENUI
A HEUKING team led by Munich-based M&A Partners Boris Dürr and Christian Schild comprehensively advised Luxempart S.A., a Luxembourg-based publicly listed investment company, on its acquisition of a majority interest in VALEARA group, a leading provider of outpatient mental health services. The sellers were private equity investor GENUI and the company’s founders.
VALEARA group is making a significant contribution to mental healthcare in Germany through an integrated, interdisciplinary care model. It provides patients with rapid access to high-quality treatment options, including psychiatric outpatient clinics, day clinics, specialist practices, and facilities for child and adolescent psychiatry. The group is also investing in the future of care by systematically training therapeutic professionals through its own academy. VALEARA currently employs approximately 1,000 people across 15 facilities at 13 sites, treats around 220,000 outpatient cases annually, and records about 40,000 patient days per year in its day clinics.
The transaction structure provides for a reinvestment by the existing shareholders led by GENUI. Together with Luxempart and the management team led by CEO Dr. Christian Utler, they will support VALEARA group in its next expansion phase. Luxempart’s investment is intended to preserve and further strengthen the group’s distinctive corporate culture and its consistent focus on delivering high-quality treatment outcomes for patients.
Luxempart is a publicly listed investment company headquartered in Luxembourg, with net assets of approximately EUR 2.5 billion. As a long-term investor, Luxempart supports its portfolio companies with capital and expertise and pursues a partnership-based growth strategy across its European core markets of France, the Benelux countries, the DACH region, and Northern Italy. Its experienced team of nearly 30 investment and support professionals combines an entrepreneurial mindset with a track record spanning more than 30 years.
GENUI is a private equity firm founded in 2014 by renowned entrepreneurs and investment experts. It operates offices in Hamburg and Zurich. Backed by a network of more than 30 entrepreneurs, GENUI invests in market-leading companies focused on health, sustainable transformation, and digitalization.
Counsel to Luxempart S.A.
HEUKING:
Boris Dürr (Lead, Private Equity/M&A),
Christian Schild, LL.M. (London),
Marcel Greubel,
Felix Noack,
Marilena Schöck,
Dr. Martin Ströhmann, LL.M. (Chicago), (all Corporate / M&A),
Dr. Oliver Treptow,
Catarina Angelika Gröger, LL.M.,
Kim Anna Schwick (all Health Care),
Peter Michael Schäffler (Tax),
Dr. Karolina Magdalena Badura (Financing),
Dr. Reinhard Siegert,
Dr. Ruth Jungkind (both Antitrust),
Sophia Schock,
Bettina Neheider (both Public Law/Subsidies),
Dr. Julia Christine Mattes (IP), all Munich,
Dr. Bodo Matthäus Dehne (Foreign Trade),
Fabian Schmitz (Real Estate),
Michael Kuska, LL.M., LL.M. (IT),
Dr. Eylem Kaya, LL.M., (Health Care),
Julian Rosenfeld (IT), all Düsseldorf,
Kerstin Deiters, LL.M., EMBA,
Leana Loewke (both Employment), both Cologne
